Fig. 6From: In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancerIn vivo antitumor effects of TGZ. a Tumor volume. Balb/c male mice were subcutaneously inoculated in the back with MIA Paca2 cells (5āĆā106 cells) 14Ā days before the start of TGZ administration. Mice were then orally administered vehicle (control, nā=ā10) or 200Ā mg/kg of TGZ (nā=ā8) daily for 5Ā weeks. Tumor volume was measured bi-dimensionally and volume was calculated by the formula (lengthāĆāwidth2)āĆā0.5. b Mouse body weights were monitored throughout the experiment. Data are presented as meanāĀ±āSD. * pā<ā0.05 and ** pā<ā0.01 vs. control on each individual day (t-test). TGZ, troglitazoneBack to article page